BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 293.60
-4.60 (-1.54%)
Oct 13, 2026, 12:39 PM CET
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of 26.05 billion as of October 12, 2026. It is the 5,645th most valuable company in the world and the 64th biggest in Sweden. Its market cap has increased by 0.99% in one year.
Market Cap
26.05B
Enterprise Value
24.15B
Revenue
1.00B
Global Rank
Country Rank
#64 Sweden
PE Ratio
251.78
ChartMarket Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 2.55B to 26.05B, an increase of 920.05%. That is a compound annual growth rate of 29.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 26.05B | -5.45% |
| Dec 30, 2025 | 27.55B | 56.23% |
| Dec 30, 2024 | 17.63B | -25.44% |
| Dec 29, 2023 | 23.65B | -1.34% |
| Dec 30, 2022 | 23.97B | 128.37% |
| Dec 30, 2021 | 10.50B | 24.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Camurus AB | 38.06B |
| Egetis Therapeutics AB | 4.63B |
| Hansa Biopharma AB | 3.68B |
| Vicore Pharma Holding AB | 2.58B |
| BioInvent International AB | 1.52B |
| Genovis AB (publ.) | 1.39B |
| Flerie AB | 1.31B |
| Saniona AB | 1.25B |